Literature DB >> 9660117

Pediatric brain stem gliomas: an update.

G Rubin1, S Michowitz, G Horev, Z Herscovici, I J Cohen, A Shuper, Z H Rappaport.   

Abstract

It has become evident that pediatric brain stem gliomas are a heterogeneous pathology and should be classified according to clinical and radiological criteria. This classification has contributed to better treatment and greatly improved prognosis. Based on a review of the literature, we describe the different types of brain stem astrocytomas reported, which are: cervicomedullary, exophytic, cystic, focal and diffuse. Particular attention is paid to therapeutic modalities. For the first three lesions named the treatment is surgical and oncological therapy should be evaluated only for regrowth of the mass. Focal tumors of the medulla and pons are still treated empirically (surgically and/or with radiotherapy), because a definitive therapeutic protocol has not yet been elaborated; on the other hand it is well established that if the focal mass is in the midbrain this should merely be monitored by means of serial MRI, while radiotherapy should be applied in the event of the tumor's growth. Diffuse gliomas are treated with oncological therapy, and surgery (for biopsy or tumor excision) is not indicated. Five illustrative cases from our department are presented.

Entities:  

Mesh:

Year:  1998        PMID: 9660117     DOI: 10.1007/s003810050205

Source DB:  PubMed          Journal:  Childs Nerv Syst        ISSN: 0256-7040            Impact factor:   1.475


  17 in total

1.  Treatment of childhood diffuse brain stem tumors: comparison of results in different treatment modalities.

Authors:  Melissa M de Aquino Gorayeb; Salim Aisen; Wladimir Nadalin; Rodrigo Panico Gorayeb; Heloisa de Andrade Carvalho
Journal:  Clin Transl Oncol       Date:  2006-01       Impact factor: 3.405

Review 2.  Long-term survival of an infant with diffuse brainstem lesion diagnosed by prenatal MRI: a case report and review of the literature.

Authors:  M Suo-Palosaari; H Rantala; S Lehtinen; T Kumpulainen; N Salokorpi
Journal:  Childs Nerv Syst       Date:  2016-02-23       Impact factor: 1.475

3.  Modeling DIPG in the mouse brainstem.

Authors:  Robert Siddaway; Cynthia Hawkins
Journal:  Neuro Oncol       Date:  2020-03-05       Impact factor: 12.300

4.  Protein profiling of formalin fixed paraffin embedded tissue: Identification of potential biomarkers for pediatric brainstem glioma.

Authors:  Javad Nazarian; Mariarita Santi; Yetrib Hathout; Tobey J Macdonald
Journal:  Proteomics Clin Appl       Date:  2008-06       Impact factor: 3.494

5.  Management of childhood brain tumors: consensus report by the Pediatric Hematology Oncology (PHO) Chapter of Indian Academy of Pediatrics (IAP).

Authors:  Sunil Bhat; Satya Prakash Yadav; Vaishali Suri; Rana Patir; Purna Kurkure; Stewart Kellie; Anupam Sachdeva
Journal:  Indian J Pediatr       Date:  2011-06-22       Impact factor: 1.967

6.  Paediatric brain-stem gliomas: MRI, FDG-PET and histological grading correlation.

Authors:  Jong Won Kwon; In-One Kim; Jung-Eun Cheon; Woo Sun Kim; Sung Gyu Moon; Tae Jung Kim; Je Geun Chi; Kyu-Chang Wang; June Key Chung; Kyung Mo Yeon
Journal:  Pediatr Radiol       Date:  2006-07-18

Review 7.  Childhood brain tumors: accomplishments and ongoing challenges.

Authors:  Roger J Packer
Journal:  J Child Neurol       Date:  2008-10       Impact factor: 1.987

8.  Metabolism of diffuse intrinsic brainstem gliomas in children.

Authors:  Ashok Panigrahy; Marvin D Nelson; Jonathan L Finlay; Richard Sposto; Mark D Krieger; Floyd H Gilles; Stefan Blüml
Journal:  Neuro Oncol       Date:  2007-11-14       Impact factor: 12.300

9.  Bevacizumab and irinotecan treatment for progressive diffuse brainstem glioma: case report.

Authors:  Roy Torcuator; Richard Zuniga; Randa Loutfi; Tom Mikkelsen
Journal:  J Neurooncol       Date:  2009-01-13       Impact factor: 4.130

10.  Motexafin gadolinium and involved field radiation therapy for intrinsic pontine glioma of childhood: a Children's Oncology Group phase I study.

Authors:  Kristin A Bradley; Ian F Pollack; Joel M Reid; Peter C Adamson; Matthew M Ames; Gilbert Vezina; Susan Blaney; Percy Ivy; Tianni Zhou; Mark Krailo; Gregory Reaman; Minesh P Mehta
Journal:  Neuro Oncol       Date:  2008-08-20       Impact factor: 12.300

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.